164 related articles for article (PubMed ID: 9726639)
1. Synthesis of dopamine from L-3,4-dihydroxyphenylalanine by human amniotic epithelial cells.
Elwan MA
Eur J Pharmacol; 1998 Jul; 354(1):R1-2. PubMed ID: 9726639
[TBL] [Abstract][Full Text] [Related]
2. Uptake and decarboxylation of L-3,4-dihydroxyphenylalanine in cultured monkey placenta amniotic epithelial cells.
Elwan MA; Sakuragawa N
Placenta; 2007; 28(2-3):245-8. PubMed ID: 16580727
[TBL] [Abstract][Full Text] [Related]
3. Uptake and intracellular fate of L-DOPA in a human intestinal epithelial cell line: Caco-2.
Vieira-Coelho MA; Soares-Da-Silva P
Am J Physiol; 1998 Jul; 275(1):C104-12. PubMed ID: 9688840
[TBL] [Abstract][Full Text] [Related]
4. Apical and basolateral uptake and intracellular fate of dopamine precursor L-dopa in LLC-PK1 cells.
Soares-Da-Silva P; Serrão MP; Vieira-Coelho MA
Am J Physiol; 1998 Feb; 274(2):F243-51. PubMed ID: 9486218
[TBL] [Abstract][Full Text] [Related]
5. Endogenous dopamine synthesis and dopa-decarboxylase activity in rat renal cortex.
Wahbe F; Hagege J; Loreau N; Ardaillou R
Mol Cell Endocrinol; 1982 Jun; 27(1):45-54. PubMed ID: 7106369
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic acinar cells utilize tyrosine to synthesize L-dihydroxyphenylalanine.
Li GW; Li J; Feng XY; Chen H; Chen Y; Liu JH; Zhang Y; Hong F; Zhu JX
Exp Biol Med (Maywood); 2021 Dec; 246(23):2533-2542. PubMed ID: 34313482
[TBL] [Abstract][Full Text] [Related]
7. L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.
Shimamura M; Shimizu M; Yagami T; Funabashi T; Kimura F; Kuroiwa Y; Misu Y; Goshima Y
Neuropharmacology; 2006 Jun; 50(8):909-16. PubMed ID: 16504219
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
[TBL] [Abstract][Full Text] [Related]
9. Uptake of L-3,4-dihydroxyphenylalanine and dopamine formation in cultured renal epithelial cells.
Soares-da-Silva P; Vieira-Coelho MA; Serrão MP
Biochem Pharmacol; 1997 Nov; 54(9):1037-46. PubMed ID: 9374425
[TBL] [Abstract][Full Text] [Related]
10. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
Alachkar A; Brotchie JM; Jones OT
Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
[TBL] [Abstract][Full Text] [Related]
11. Production of Dopamine by Aromatic l-Amino Acid Decarboxylase Cells after Spinal Cord Injury.
Ren LQ; Wienecke J; Hultborn H; Zhang M
J Neurotrauma; 2016 Jun; 33(12):1150-60. PubMed ID: 26830512
[TBL] [Abstract][Full Text] [Related]
12. Increase in plasma 3,4-dihydroxyphenylalanine (DOPA) appearance rate after inhibition of DOPA decarboxylase in humans.
Eldrup E; Hetland ML; Christensen NJ
Eur J Clin Invest; 1994 Mar; 24(3):205-11. PubMed ID: 8033956
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells.
Tehranian R; Montoya SE; Van Laar AD; Hastings TG; Perez RG
J Neurochem; 2006 Nov; 99(4):1188-96. PubMed ID: 16981894
[TBL] [Abstract][Full Text] [Related]
14. Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus.
Robert F; Lambás-Señas L; Ortemann C; Pujol JF; Renaud B
J Neurochem; 1993 Feb; 60(2):721-9. PubMed ID: 8093483
[TBL] [Abstract][Full Text] [Related]
15. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
Silva MA; Mattern C; Häcker R; Tomaz C; Huston JP; Schwarting RK
Synapse; 1997 Dec; 27(4):294-302. PubMed ID: 9372552
[TBL] [Abstract][Full Text] [Related]
16. Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
Buck K; Ferger B
Neurobiol Dis; 2008 Feb; 29(2):210-20. PubMed ID: 17920284
[TBL] [Abstract][Full Text] [Related]
17. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
Jonkers N; Sarre S; Ebinger G; Michotte Y
J Neural Transm (Vienna); 2001; 108(5):559-70. PubMed ID: 11459076
[TBL] [Abstract][Full Text] [Related]
18. Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat.
Tayarani-Binazir KA; Jackson MJ; Strang I; Jairaj M; Rose S; Jenner P
Behav Pharmacol; 2012 Apr; 23(2):126-33. PubMed ID: 22236652
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic secretion of dopamine after inhibition of aromatic L-amino acid decarboxylase activity.
Reymond MJ; Porter JC
Endocrinology; 1982 Oct; 111(4):1051-6. PubMed ID: 6811255
[TBL] [Abstract][Full Text] [Related]
20. Dopamine synthesis by non-dopaminergic neurons in the arcuate nucleus of rat fetuses.
Mel'nikova VI; Lavrent'eva AV; Kudrin VS; Raevskii KS; Ugryumov MV
Neurosci Behav Physiol; 2005 Oct; 35(8):809-13. PubMed ID: 16132261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
